These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34695855)

  • 1. Microvascular Skin Manifestations Caused by COVID-19.
    Gawaz A; Guenova E
    Hamostaseologie; 2021 Oct; 41(5):387-396. PubMed ID: 34695855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.
    Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W
    Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood clots in COVID-19 patients: Simplifying the curious mystery.
    Biswas S; Thakur V; Kaur P; Khan A; Kulshrestha S; Kumar P
    Med Hypotheses; 2021 Jan; 146():110371. PubMed ID: 33223324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective.
    Dalan R; Boehm BO
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3402. PubMed ID: 32871617
    [No Abstract]   [Full Text] [Related]  

  • 5. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
    Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications.
    Ma Z; Yang KY; Huang Y; Lui KO
    J Mol Cell Cardiol; 2022 Mar; 164():69-82. PubMed ID: 34838588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?
    Alvarado-Vasquez N
    Med Hypotheses; 2021 Jan; 146():110378. PubMed ID: 33189452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
    Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
    Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic short linear motifs in ACE2 and integrin β
    Kliche J; Kuss H; Ali M; Ivarsson Y
    Sci Signal; 2021 Jan; 14(665):. PubMed ID: 33436498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
    Maruhashi T; Higashi Y
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets and COVID-19.
    Rohlfing AK; Rath D; Geisler T; Gawaz M
    Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation.
    Reynolds JL; Mahajan SD
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):4-6. PubMed ID: 33405097
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.
    Hallaj S; Ghorbani A; Mousavi-Aghdas SA; Mirza-Aghazadeh-Attari M; Sevbitov A; Hashemi V; Hallaj T; Jadidi-Niaragh F
    Immunol Cell Biol; 2021 Feb; 99(2):192-205. PubMed ID: 32864784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
    Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapulmonary SARS-CoV-2 manifestations.
    Carvalho T
    Nat Med; 2020 Dec; 26(12):1806. PubMed ID: 33288941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.